期刊文献+

维持性腹膜透析患者血清半乳糖凝集素3水平与心血管疾病的相关性研究 被引量:2

Correlation between serum galectin-3 and cardiovascular disease in maintenance peritoneal dialysis patients
原文传递
导出
摘要 目的观察维持性腹膜透析(maintenance peritoneal dialysis,MPD)患者血清半乳糖凝集素3(galectin-3,Gal-3)的表达情况,并探讨其与心血管疾病(cardiovascular disease,CVD)的相关性。方法选取MPD患者80例及健康对照组40例为研究对象。收集患者年龄、性别、有无CVD病史等临床信息,根据有无CVD发生,分为CVD组和无CVD组。检测血清Gal-3、血红蛋白(Hb)等指标;并记录心脏彩超检查结果。结果(1)MPD组血清Gal-3水平明显高于健康对照组;(2)以年龄校正后,血清Gal-3与Hb、舒张压呈正相关,与血清白蛋白(Alb)、残余肾功能呈负相关;(3)CVD组血清Gal-3、Hb、血磷、左心房内径(left artrial diameter,LAD)、左心室舒张末期内径、室间隔厚度明显高于无CVD组,而Alb、左心室射血分数明显低于无CVD组;(4)多因素Logistic回归显示,Gal-3、Hb、Alb、LAD值是MPD患者发生CVD的独立危险因素。结论MPD患者血清Gal-3水平明显升高,血清Gal-3、Hb、Alb、LAD值是MPD患者发生CVD的独立危险因素。 Objective To determine the level of serum galectin-3(Gal-3)and its correlation with cardiovascular disease(CVD)in maintenance peritoneal dialysis(MPD)patients.Methods Eighty MPD patients and 40 healthy controls were recruited.Control group which matched with age and sex of MPD were selected from medical examination center.Age,sex,with or without CVD history,hemoglobin(Hb),serum Gal-3 and echocardiography were recorded.According to CVD history,the patients were divided into CVD group and non-CVD group.Results(1)Serum Gal-3 in MPD group was significantly higher than healthy controls.(2)After adjustment for age,serum Gal-3 in MPD patients was positively related to Hb and diastolic pressure,and negatively related to serum albumin(Alb)and residual renal function.(3)Compared with non-CVD group,patients in CVD group had significantly increased Hb,serum phosphorus,serum Gal-3,left artrial diameter(LAD),left ventricular diameter,and interventricular spetum,but significantly reduced Alb and left ventricular ejection.(4)Multivariate Logistic regression analysis showed that Hb,Alb,LAD,and serum Gal-3 were independently correlated with CVD in MPD patients.Conclusion Serum Gal-3 in MPD patients is significantly elevated.Serum Gal-3,Hb,Alb and LAD are independent risk factors of CVD in MPD patients.
作者 滕兰波 刘书馨 王胜男 陈琛 简雪莲 李雨竹 TENG Lan-bo;LIU Shu-xin;WANG Sheng-nan;CHEN Chen;JIAN Xue-lian;LI Yu-zhu(Department of Nephrology,Dalian Central Hospital,Dalian 116033,China)
出处 《哈尔滨医科大学学报》 CAS 2020年第5期498-502,共5页 Journal of Harbin Medical University
基金 大连市医学科学研究计划项目(1711003)
关键词 半乳糖凝集素3 腹膜透析 心血管疾病 galectin-3 peritoneal dialysis cardiovascular disease
  • 相关文献

参考文献2

二级参考文献33

  • 1World Health Organization. Worldwide Prevalence of Anaemia 1993- 2005 : WHO Global Database on Anaemia. In : de Benoist B, McLean E, Egli I and M Cogswell (eds) ,2005.
  • 2Mireeseu G, G:rneata L, Capusa C, et al. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrol Dial Transplant, 2006, 21 ( 1 ) : 120-124.
  • 3Sunder-Plassmann G, H:rl WH. Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant, 1995, 10 ( 11 ) : 2070-2076.
  • 4Stancu S, B:san L, Stanciu A, et al. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? Clin J Am Soc Nephrol,2010,5(3) :409-416.
  • 5Kalantar-Zadeh K, Htiffken B, Wiinsch H, et al. Diagnosis of iron deficiency anemia in renal failure patients during the post- erythropoietin era. Am J Kidney Dis, 1995,26(2) :292-299.
  • 6Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ, 1990,300 (6724) : 573-578.
  • 7KDOQI. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease:2007 update of hemoglobin target. Am J Kidney Dis,2007,50(3) :471-530.
  • 8Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med, 2009, 361(21) :2019-2032.
  • 9Palmer SC, Navaneethan SD, Craig JC, et al. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med, 2010,153 (1 ) : 23-33.
  • 10Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematoerit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med, 1998,339 (9) : 584-590.

共引文献38

同被引文献25

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部